Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18245785 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
Condition: Multiple Sclerosis
Interventions: Drug: Feraheme;   Drug: Gadolinium-based contrast

Indicates status has not been verified in more than two years